NoMy is a Norwegian startup that researches and develops sustainable material and food solutions using mycelium. The fungal biology company expects to generate alternatives to plastic, bio-composites, novel meat solutions, and alternative protein sources. The company expects to operate a B2B business model to commercialize its product offerings.
Key customers and partnerships
In March 2021, NoMy partnered with The Life Science Cluster (a network connecting people, companies and resources in Norway’s life science sector) to expand their reach, and further, to obtain necessary aid in financing, strategic development, regulations, and policies.
Funding and financials
NoMy raised an undisclosed amount in a seed funding round with participation from investors We Are Human, TRK, StartupLab Founders, and Firda in August 2021. The funds are expected to support NoMy’s ongoing research and development initiatives on ‘future green materials’, which includes alternatives to plastics and sustainably produced materials, alongside novel foods and alternative protein solutions produced via mycelium.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.